Cortexyme, Inc. (CRTX) Social Stream



Cortexyme, Inc. (CRTX): $12.03

-0.19 (-1.55%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CRTX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 476

in industry

Cortexyme Inc (CRTX) Price Targets From Analysts

Use the tables below to see what analysts covering Cortexyme Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
7 $221 $14 $108.43 $17.12 533.35%

The Trend in the Analyst Price Target


CRTX's average price target has moved up $24.72 over the prior 37 weeks.

CRTX reports an average of 71.97% for its upside potential over the past 16 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-20 7 221 14 108.43 85.65 26.6%
2021-09-19 7 221 14 108.43 87.79 23.51%
2021-09-18 7 221 14 108.43 87.79 23.51%
2021-09-11 7 221 14 97.71 91.08 7.28%
2021-09-04 7 221 14 97.71 92.90 5.18%
2021-08-28 7 221 14 97.71 105.89 -7.72%
2021-08-14 7 221 14 80.00 100.07 -20.06%
2021-08-07 7 221 14 78.29 67.14 16.61%
2021-08-05 7 221 14 78.29 69.16 13.2%
2021-08-01 7 221 14 78.29 56.51 38.54%
2021-07-24 7 190 14 73.86 64.20 15.05%
2021-07-17 7 190 14 73.86 53.54 37.95%
2021-07-10 7 190 14 73.86 57.45 28.56%
2021-07-03 7 190 14 73.86 55.15 33.93%
2021-06-26 7 190 14 73.86 55.73 32.53%
2021-06-13 7 190 14 71.29 48.69 46.42%
2021-06-05 7 190 14 71.29 44.85 58.95%
2021-05-22 7 190 14 71.29 37.47 90.26%
2021-05-15 7 190 14 71.29 36.77 93.88%
2021-05-08 7 190 14 71.29 37.10 92.16%
2021-04-25 7 190 14 71.29 38.26 86.33%
2021-04-17 7 190 14 71.29 38.70 84.21%
2021-04-10 7 190 14 71.29 33.59 112.24%
2021-04-03 8 190 14 66.63 37.34 78.44%
2021-03-20 8 190 14 66.63 36.50 82.55%
2021-03-13 8 190 14 66.63 39.67 67.96%
2021-03-06 8 190 14 66.63 37.99 75.39%
2021-02-27 8 190 14 66.63 34.07 95.57%
2021-02-20 8 190 14 66.63 32.47 105.2%
2021-02-13 8 213 14 75.75 47.47 59.57%
2021-02-06 8 213 14 75.75 43.85 72.75%
2021-01-30 8 213 14 75.75 39.22 93.14%
2021-01-23 8 213 14 75.75 32.10 135.98%
2021-01-16 8 213 14 75.75 32.61 132.29%
2021-01-09 8 213 14 75.75 30.44 148.85%
2021-01-02 7 213 14 83.71 27.78 201.33%
2020-12-26 7 213 14 83.71 29.00 188.66%
2020-12-19 7 213 14 83.71 28.75 191.17%
2020-12-10 7 213 14 83.71 36.80 127.47%
2020-12-07 7 213 14 83.71 40.20 108.23%
2020-11-28 7 190 14 80.43 49.42 62.75%
2020-11-16 7 190 14 80.43 51.41 56.45%
2020-11-03 7 184 14 79.57 NA NA%
2020-08-20 6 84 14 62.17 NA NA%
2020-08-20 7 184 14 79.57 NA NA%
2020-07-27 6 84 14 61.33 NA NA%
2020-06-23 6 84 14 61.33 NA NA%
2020-06-01 5 84 14 58.40 NA NA%

CRTX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.93 1 3 0 1 1 7

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • CRTX has a lower variance in analysts' estimates than 0.430000000000007% of all US stocks.
  • Cortexyme Inc's upside potential (average analyst target price relative to current price) is greater than 99.36% of stocks in the mid market cap category.
  • CRTX has a higher average analyst price target than 92.99% of Pharmaceutical Products stocks.
  • CRTX has a greater number of analysts covering the stock than 70.13% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Cortexyme Inc are ARCT, CGC and HEXO.

What is the outlook for CRTX? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 1.1421 seconds.